Patent · US Expired

Steroid 5a reductase nucleic acid segments and recombinant vectors and host cells

US5422262A · kind A · utility

18Cited by
0References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 1991
Grant dateJun 6, 1995
Priority date
Expiry dateNov 18, 2011

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y103/01022
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are methods and compositions for the preparation of steroid 5.alpha.-reductases by recombinant means, as well as for the use of these enzymes in screening assays for the identification of compounds which have the ability to inhibit or otherwise alter the enzymatic function of these enzymes. Biochemical and pharmacological evidence is presented to demonstrate the existence of more than one human steroid 5.alpha.-reductase. The DNA sequence encoding steroid 5.alpha.-reductase 2, the major active isozyme of human genital tissue, is disclosed herein, in addition to methods and compositions for its preparation and pharmacological analysis. The sequences disclosed herein may be used directly in the preparation of genetic constructs, or may be employed in the preparation of hybridization probes for the selection of enzyme-encoding sequences from other sources. These sequences may prove useful in an analysis of normal and abnormal sexual differentiation, benign prostatic hyperplasia, male pattern baldness, acne, hirsutism, endometriosis, and cancer of the prostate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.